Zynerba Pharmaceuticals Stock Forecast - Market Facilitation Index
| ZYNEDelisted Stock | USD 0.36 0.01 2.70% |
Zynerba Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Zynerba Pharmaceuticals stock prices and determine the direction of Zynerba Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Zynerba Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Zynerba |
| Check Zynerba Pharmaceuticals Volatility | Backtest Zynerba Pharmaceuticals | Information Ratio |
Zynerba Pharmaceuticals Trading Date Momentum
| On November 30 2024 Zynerba Pharmaceuticals was traded for 0.36 at the closing time. The top price for the day was 0.38 and the lowest listed price was 0.36 . There was no trading activity during the period 0.0. Lack of trading volume on November 30, 2024 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 2.78% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare Zynerba Pharmaceuticals to competition
View Zynerba Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Zynerba Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Zynerba Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zynerba Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zynerba Pharmaceuticals stock market strength indicators, traders can identify Zynerba Pharmaceuticals entry and exit signals to maximize returns.
Zynerba Pharmaceuticals Risk Indicators
The analysis of Zynerba Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zynerba Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zynerba stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.36 | |||
| Standard Deviation | 4.2 | |||
| Variance | 17.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |